|
HUP9902721A2
(hu)
|
1997-11-25 |
1999-12-28 |
The Procter & Gamble Co. |
Tömény textillágyító készítmény és ehhez alkalmazható magas telítetlenségű textillágyító vegyület
|
|
CA2343038A1
(en)
*
|
1998-09-28 |
2000-04-06 |
Maria Emanuel Ryan |
A novel inhibitor of cataract formation
|
|
US6914057B1
(en)
|
1998-09-28 |
2005-07-05 |
The Research Foundation Of State University Of New York |
Inhibitor of cataract formation
|
|
AU2002254940A1
(en)
*
|
2001-03-12 |
2002-09-24 |
Novartis Pharma Gmbh |
Combination of nateglinide or repaglinide with at least one further antidiabetic compound
|
|
EP2311440A1
(en)
*
|
2001-04-05 |
2011-04-20 |
Collagenex Pharmaceuticals, Inc. |
Controlled delivery of tetracycline compounds and tetracycline derivatives
|
|
FR2826278B1
(fr)
*
|
2001-06-20 |
2005-03-25 |
Lipha |
Utilisation d'agents antidiabetiques pour fabriquer un medicament ayant un effet cicatrisant
|
|
DE60216453T2
(de)
*
|
2001-06-20 |
2007-09-20 |
Merck Santé |
Verwendung von antidiabetika zur herstellung eines vernarbungsfördernden arzneimittels
|
|
EP2327409A1
(en)
|
2001-07-13 |
2011-06-01 |
Paratek Pharmaceuticals, Inc. |
Tetracycline compound having target therapeutic activities
|
|
AU2002359730A1
(en)
*
|
2001-12-21 |
2003-07-30 |
Smithkline Beecham Corporation |
Compositions and methods for altering glucose production
|
|
ES2551708T3
(es)
|
2002-01-08 |
2015-11-23 |
Paratek Pharmaceuticals, Inc. |
Compuestos de 4-desdimetilamino tetraciclina
|
|
EP2311451A1
(en)
|
2002-03-08 |
2011-04-20 |
Paratek Pharmaceuticals, Inc. |
Amino-methyl substituted tetracycline compounds
|
|
EP1503981A4
(en)
|
2002-03-21 |
2007-08-15 |
Paratek Pharm Innc |
SUBSTITUTED TETRACYCLINE COMPOUNDS
|
|
AU2003261161B2
(en)
|
2002-07-12 |
2009-09-10 |
Paratek Pharmaceuticals, Inc |
3, 10, and 12a substituted tetracycline compounds
|
|
WO2004091483A2
(en)
|
2003-04-07 |
2004-10-28 |
Shire Laboratories, Inc. |
Once daily formulations of tetracyclines
|
|
AU2004259661B2
(en)
|
2003-07-09 |
2011-11-10 |
Paratek Pharmaceuticals, Inc. |
Prodrugs of 9-aminomethyl tetracycline compounds
|
|
US20050143352A1
(en)
|
2003-07-09 |
2005-06-30 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds
|
|
JP5010284B2
(ja)
*
|
2004-01-15 |
2012-08-29 |
パラテック ファーマシューティカルズ インコーポレイテッド |
テトラサイクリン化合物の芳香族ａ環誘導体
|
|
EP1805134B1
(en)
|
2004-10-25 |
2012-06-20 |
Paratek Pharmaceuticals, Inc. |
4-aminotetracyclines and methods of use thereof
|
|
EP2033950A1
(en)
|
2004-10-25 |
2009-03-11 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds
|
|
US20070093455A1
(en)
*
|
2005-07-21 |
2007-04-26 |
Paul Abato |
10-substituted tetracyclines and methods of use thereof
|
|
US20070098763A1
(en)
*
|
2005-10-11 |
2007-05-03 |
Sinnott Robert A |
Soluble Fiber Combinations for Weight Control and Improving Parameters of Cardiovascular Health
|
|
CA2892739A1
(en)
|
2006-12-21 |
2008-07-03 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds for treatment of inflammatory skin disorders
|
|
WO2008079339A2
(en)
|
2006-12-21 |
2008-07-03 |
Paratek Pharmaceuticals, Inc. |
Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
|
|
EP2216323A3
(en)
*
|
2007-04-27 |
2010-12-29 |
Paratek Pharmaceuticals, Inc. |
Methods for synthesizing and purifying aminoalkyl tetracycline compounds
|
|
EP2176216B1
(en)
*
|
2007-07-06 |
2012-04-25 |
Paratek Pharmaceuticals, Inc. |
Methods for synthesizing 9-substituted minocycline
|
|
TWI680117B
(zh)
|
2008-05-19 |
2019-12-21 |
派洛泰克藥物股份有限公司 |
四環素化合物之甲苯磺酸鹽及同素異形體
|
|
KR101746795B1
(ko)
|
2008-08-08 |
2017-06-13 |
테트라페이즈 파마슈티컬스, 인코포레이티드 |
Ｃ７-플루오로 치환된 테트라시클린 화합물
|
|
WO2010129057A2
(en)
|
2009-05-08 |
2010-11-11 |
Tetraphase Pharmaceuticals, Inc. |
Tetracycline compounds
|
|
NO2470500T3
(https=)
|
2009-08-28 |
2018-03-03 |
|
|
|
DK2552890T3
(en)
|
2010-03-31 |
2017-04-03 |
Tetraphase Pharmaceuticals Inc |
POLYCYCLIC TETRACYCLINE COMPOUNDS
|
|
CA2883238C
(en)
|
2012-08-31 |
2021-11-23 |
Tetraphase Pharmaceuticals, Inc. |
Tetracycline compounds
|
|
US9171343B1
(en)
|
2012-09-11 |
2015-10-27 |
Aseko, Inc. |
Means and method for improved glycemic control for diabetic patients
|
|
US9897565B1
(en)
|
2012-09-11 |
2018-02-20 |
Aseko, Inc. |
System and method for optimizing insulin dosages for diabetic subjects
|
|
US9486580B2
(en)
|
2014-01-31 |
2016-11-08 |
Aseko, Inc. |
Insulin management
|
|
US9898585B2
(en)
|
2014-01-31 |
2018-02-20 |
Aseko, Inc. |
Method and system for insulin management
|
|
EP3933845A3
(en)
|
2014-10-27 |
2022-06-22 |
Aseko, Inc. |
Subcutaneous outpatient management
|
|
US11081226B2
(en)
|
2014-10-27 |
2021-08-03 |
Aseko, Inc. |
Method and controller for administering recommended insulin dosages to a patient
|
|
EP3337402B1
(en)
|
2015-08-20 |
2026-01-07 |
Glytec, LLC |
Diabetes management therapy advisor
|
|
HUE066360T2
(hu)
|
2016-10-19 |
2024-07-28 |
Tetraphase Pharmaceuticals Inc |
Eravaciklin kristályformái
|
|
US12570604B2
(en)
|
2018-11-09 |
2026-03-10 |
Tetraphase Pharmaceuticals, Inc. |
Polymorphic forms of a tetracycline compound and uses thereof
|
|
PH12021552866A1
(en)
|
2019-05-14 |
2022-11-07 |
Tyme Inc |
Compositions and methods for treating cancer
|
|
WO2021207487A1
(en)
*
|
2020-04-08 |
2021-10-14 |
Hoffman Technologies Llc |
Methods of treating conditions characterized by insulin deficiency in animals
|
|
US10905698B1
(en)
|
2020-05-14 |
2021-02-02 |
Tyme, Inc. |
Methods of treating SARS-COV-2 infections
|